Home » POSITRON RECEIVES FUNDING FROM PRIVATE INVESTMENT GROUP

POSITRON RECEIVES FUNDING FROM PRIVATE INVESTMENT GROUP

June 2, 2006

Positron Corporation, a developer and manufacturer of positron emission tomography (PET) medical devices, announced June 2 that the Company has completed a financing agreement for $2,000,000 with private investors.
TMCnet

KEYWORDS FDAnews Device Daily Bulletin

10Mar
FDA Drug GMP Facility Inspections During the Pandemic
16Mar
Pharmaceutical Naming Regulation: Understanding the Latest Developments
18Mar
Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19
23Mar
Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges
30Mar
Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges
06Apr
Medical Device Cybersecurity: Understand the Latest Developments

POSITRON RECEIVES FUNDING FROM PRIVATE INVESTMENT GROUP

Upcoming Events

FDA Drug GMP Facility Inspections During the Pandemic

Pharmaceutical Naming Regulation: Understanding the Latest Developments

Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

Biological Risk Evaluation and Management for Medical Devices

GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

AstraZeneca Withdraws Imfinzi’s Bladder Cancer Indication

Cue Health’s COVID-19 Test Receives CE Mark

Sanofi’s and Regeneron’s Libtayo Wins FDA Approval for NSCLC

PerkinElmer’s Rapid Point-of-Care COVID-19 Test Cleared in Europe

The Revised ICH E8: A Guide to New Clinical Trial Requirements